These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8006381)

  • 1. Onchocerca volvulus infections in chimpanzees: an assessment of the requirements for vaccination trials.
    Taylor MJ
    J Helminthol; 1994 Mar; 68(1):3-6. PubMed ID: 8006381
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onchocerca volvulus: comparative analysis of antibody responses to recombinant antigens in two animal models of onchocerciasis.
    Graham SP; Lustigman S; Trees AJ; Bianco AE
    Exp Parasitol; 2000 Mar; 94(3):158-62. PubMed ID: 10831380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Onchocerca spp. in animal hosts.
    Abraham D; Lucius R; Trees AJ
    Trends Parasitol; 2002 Apr; 18(4):164-71. PubMed ID: 11998704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onchocerca volvulus: parasitologic and serologic responses in experimentally infected chimpanzees and mangabey monkeys.
    Eberhard ML; Dickerson JW; Tsang VC; Walker EM; Ottesen EA; Chandrashekar R; Weil GJ; Trpis M; Strobert E; Constantinidis I
    Exp Parasitol; 1995 May; 80(3):454-62. PubMed ID: 7729480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents.
    Taylor MJ; Jenkins RE; Bianco AE
    Parasite Immunol; 1996 May; 18(5):219-25. PubMed ID: 9229374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.
    Soboslay PT; Weiss N; Dreweck CM; Taylor HR; Brotman B; Schulz-Key H; Greene BM
    Exp Parasitol; 1992 Jun; 74(4):367-80. PubMed ID: 1592090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
    George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ivermectin prophylaxis on antibody responses to Onchocerca volvulus recombinant antigens in experimentally infected chimpanzees.
    Chandrashekar R; Van Swinderen B; Taylor HR; Weil GJ
    Int J Parasitol; 1995 Aug; 25(8):983-8. PubMed ID: 8550298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a recombinant T cell and B cell reactive polypeptide of Onchocerca volvulus.
    Seeber F; Brattig N; Soboslay PT; Pogonka T; Lörz A; Strote G; Beck E; Titanji VP; Lucius R
    J Immunol; 1993 Apr; 150(7):2931-44. PubMed ID: 8454865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis.
    Harrison RA; Bianco AE
    Parasite Immunol; 2000 May; 22(5):249-57. PubMed ID: 10792764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
    MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
    Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerca volvulus: immunization of chimpanzees with X-irradiated third-stage (L3) larvae.
    Prince AM; Brotman B; Johnson EH; Smith A; Pascual D; Lustigman S
    Exp Parasitol; 1992 May; 74(3):239-50. PubMed ID: 1582477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
    Hess JA; Zhan B; Torigian AR; Patton JB; Petrovsky N; Zhan T; Bottazzi ME; Hotez PJ; Klei TR; Lustigman S; Abraham D
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004797. PubMed ID: 27387453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recognition of Onchocerca volvulus proteins in the human host and animal models of onchocerciasis.
    Manchang TK; Ajonina-Ekoti I; Ndjonka D; Eisenbarth A; Achukwi MD; Renz A; Brattig NW; Liebau E; Breloer M
    J Helminthol; 2015 May; 89(3):375-86. PubMed ID: 24721822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.
    Abraham D; Leon O; Leon S; Lustigman S
    Infect Immun; 2001 Jan; 69(1):262-70. PubMed ID: 11119514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).
    Lucius R; Kern A; Seeber F; Pogonka T; Willenbücher J; Taylor HR; Pinder M; Ghalib HW; Schulz-Key H; Soboslay P
    Trop Med Parasitol; 1992 Sep; 43(3):139-45. PubMed ID: 1281926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection.
    Lobos E; Weiss N; Karam M; Taylor HR; Ottesen EA; Nutman TB
    Science; 1991 Mar; 251(5001):1603-5. PubMed ID: 2011741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.